All the news articles and press releases in one place.


Date / Time Source Company % Chg Sector Market Cap Announcement
12Apr21 16:00 RNS IXICO Plc 8.16% Various Various Holding(s) in Company
12Apr21 07:00 RNS IXICO Plc 8.16% Various Various Investment in Ixico plc
01Apr21 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
25Mar21 09:14 RNS IXICO Plc 8.16% Health £38.1m PDMR Transaction
23Mar21 15:05 RNS IXICO Plc 8.16% Health £38.1m Huntington’s disease Phase III contract updates
15Mar21 07:00 RNS IXICO Plc 8.16% Health £38.1m Collaboration with Microsoft
10Mar21 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO chosen for new Phase II AD study
02Mar21 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO selected by Cyclerion for a new AD study
01Mar21 17:25 RNS IXICO Plc 8.16% Health £38.1m Exercise of Options; PDMR Dealing
29Jan21 10:19 RNS IXICO Plc 8.16% Health £38.1m PDMR Dealing
21Jan21 11:05 RNS IXICO Plc 8.16% Health £38.1m Result of AGM
07Jan21 07:00 RNS IXICO Plc 8.16% Health £38.1m Issue of Equity
24Dec20 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO secures new contract for £3.4 million
14Dec20 11:54 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
08Dec20 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO contract with new large global pharma
02Dec20 07:00 RNS IXICO Plc 8.16% Health £38.1m Financial Results for the year ended 30 Sept 2020
27Nov20 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO announces £1.9 million new study award
09Nov20 07:00 RNS IXICO Plc 8.16% Health £38.1m Notice of Results
03Nov20 07:00 RNS IXICO Plc 8.16% Health £38.1m Additional Alzheimer’s disease contracts
22Oct20 07:00 RNS IXICO Plc 8.16% Health £38.1m Further Huntington’s disease contracts
19Oct20 07:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present at SCA & ARCA Global Conference
19Oct20 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading Update for year ended 30 September 2020
16Oct20 07:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO and NYU Langone Health sign agreement
29Sep20 07:00 RNS IXICO Plc 8.16% Health £38.1m >£2m contract extension win - Huntington’s disease
24Sep20 07:00 RNS IXICO Plc 8.16% Health £38.1m Collaboration with TRACK-FA NeuroimagingConsortium
21Sep20 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO selected to support Alzheimer’s trial
11Sep20 10:36 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
26Aug20 11:55 RNS-R IXICO Plc 8.16% Health £38.1m Investor presentation
24Aug20 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading Update
13Aug20 07:00 RNS-R IXICO Plc 8.16% Health £38.1m Investor Presentation
08Jul20 07:00 RNS-R IXICO Plc 8.16% Health £38.1m Conference attendance - On Helix Digital
06Jul20 07:00 RNS IXICO Plc 8.16% Health £38.1m Grant of share options
24Jun20 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading Update
20May20 07:00 RNS IXICO Plc 8.16% Health £38.1m Half yearly report to 31 March 2020
12May20 07:00 RNS IXICO Plc 8.16% Health £38.1m Notice of Results
20Apr20 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading update for H1 2020
14Apr20 07:00 RNS IXICO Plc 8.16% Health £38.1m £10.5m contract win, update on trading & COVID-19
16Mar20 09:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO announces expanded contract with Vaccinex
19Feb20 09:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present AI Segmentation Research
11Feb20 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
10Feb20 09:11 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present at Innovation Forum
03Feb20 09:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO Supports the AD Neuroimaging Initiative
23Jan20 07:00 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
17Jan20 16:34 RNS IXICO Plc 8.16% Health £38.1m Result of AGM
15Jan20 10:32 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
13Jan20 13:29 RNS IXICO Plc 8.16% Health £38.1m Issue of Equity
23Dec19 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO announces updates to client contracts
20Dec19 07:00 RNS IXICO Plc 8.16% Health £38.1m Statement re Annual Report and Notice of AGM
09Dec19 09:26 RNS IXICO Plc 8.16% Health £38.1m PDMR share sale
09Dec19 07:02 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
09Dec19 07:00 RNS IXICO Plc 8.16% Health £38.1m PDMR share purchase
05Dec19 08:22 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
04Dec19 07:00 RNS IXICO Plc 8.16% Health £38.1m Financial Results for the year ended 30 Sept 2019
02Dec19 07:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present at Alzheimer's Disease Congress
22Nov19 07:00 RNS IXICO Plc 8.16% Health £38.1m Notice of Results
05Nov19 09:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present at HD and Ataxia Conferences
04Nov19 14:51 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
30Oct19 09:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO to Present at 10th Annual CNS Summit 2019
28Oct19 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO announces client contracts and appointed CBO
18Oct19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
15Oct19 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading Update for year ended 30 September 2019
11Sep19 07:00 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
09Sep19 11:48 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
09Sep19 11:46 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
05Sep19 15:43 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
04Sep19 17:07 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
28Aug19 12:21 RNS IXICO Plc 8.16% Health £38.1m Issue of Equity
22Aug19 07:00 RNS IXICO Plc 8.16% Health £38.1m Directorate Change
20Aug19 17:38 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
19Aug19 07:00 RNS IXICO Plc 8.16% Health £38.1m Trading Update
09Aug19 07:00 RNS IXICO Plc 8.16% Health £38.1m IXICO provides update on new & current contracts
11Jul19 07:00 RNS IXICO Plc 8.16% Health £38.1m Director and PDMR share purchase
10Jun19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
31May19 07:00 RNS IP Group plc 0.74% Various Various Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
22May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Half Yearly Report to 31 March 2019
10May19 07:00 RNS IXICO Plc 8.16% Health £38.1m Notice of Results
25Apr19 07:00 RNS IXICO Plc 8.16% Health £38.1m Update for first half of year ending 31 March 2019
24Apr19 07:00 RNS IXICO Plc 8.16% Health £38.1m Announces two new biopharmaceutical contracts
12Apr19 07:00 RNS IXICO Plc 8.16% Health £38.1m Change of Adviser
19Mar19 16:20 RNS IXICO Plc 8.16% Health £38.1m Holding(s) in Company
18Mar19 12:24 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
13Mar19 07:00 RNS IXICO Plc 8.16% Health £38.1m Director/PDMR Shareholding
05Mar19 07:00 RNS-R IXICO Plc 8.16% Health £38.1m Late phase clinical study in Huntington's disease
01Mar19 07:00 RNS-R IXICO Plc 8.16% Health £38.1m IXICO chosen for new Medical Imaging & AI Centre
07Feb19 07:00 RNS IXICO Plc 8.16% Health £38.1m Appointment of Chief Financial Officer
11Dec18 07:00 RNS IXICO Plc 8.16% Health £38.1m Directorate Change
04Dec18 07:00 RNS IXICO Plc 8.16% Health £38.1m Final Results
04Dec18 07:00 RNS IXICO Plc 8.16% Health £38.1m Scope expanded with top 10 biopharma company
Date / Time Source Company % Chg
12Apr21 16:00 RNS IXICO Plc 8.16%
Holding(s) in Company
12Apr21 07:00 RNS IXICO Plc 8.16%
Investment in Ixico plc
01Apr21 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
25Mar21 09:14 RNS IXICO Plc 8.16%
PDMR Transaction
23Mar21 15:05 RNS IXICO Plc 8.16%
Huntington’s disease Phase III contract updates
15Mar21 07:00 RNS IXICO Plc 8.16%
Collaboration with Microsoft
10Mar21 07:00 RNS IXICO Plc 8.16%
IXICO chosen for new Phase II AD study
02Mar21 07:00 RNS IXICO Plc 8.16%
IXICO selected by Cyclerion for a new AD study
01Mar21 17:25 RNS IXICO Plc 8.16%
Exercise of Options; PDMR Dealing
29Jan21 10:19 RNS IXICO Plc 8.16%
PDMR Dealing
21Jan21 11:05 RNS IXICO Plc 8.16%
Result of AGM
07Jan21 07:00 RNS IXICO Plc 8.16%
Issue of Equity
24Dec20 07:00 RNS IXICO Plc 8.16%
IXICO secures new contract for £3.4 million
14Dec20 11:54 RNS IXICO Plc 8.16%
Holding(s) in Company
08Dec20 07:00 RNS IXICO Plc 8.16%
IXICO contract with new large global pharma
02Dec20 07:00 RNS IXICO Plc 8.16%
Financial Results for the year ended 30 Sept 2020
27Nov20 07:00 RNS IXICO Plc 8.16%
IXICO announces £1.9 million new study award
09Nov20 07:00 RNS IXICO Plc 8.16%
Notice of Results
03Nov20 07:00 RNS IXICO Plc 8.16%
Additional Alzheimer’s disease contracts
22Oct20 07:00 RNS IXICO Plc 8.16%
Further Huntington’s disease contracts
19Oct20 07:00 RNS-R IXICO Plc 8.16%
IXICO to Present at SCA & ARCA Global Conference
19Oct20 07:00 RNS IXICO Plc 8.16%
Trading Update for year ended 30 September 2020
16Oct20 07:00 RNS-R IXICO Plc 8.16%
IXICO and NYU Langone Health sign agreement
29Sep20 07:00 RNS IXICO Plc 8.16%
>£2m contract extension win - Huntington’s disease
24Sep20 07:00 RNS IXICO Plc 8.16%
Collaboration with TRACK-FA NeuroimagingConsortium
21Sep20 07:00 RNS IXICO Plc 8.16%
IXICO selected to support Alzheimer’s trial
11Sep20 10:36 RNS IXICO Plc 8.16%
Holding(s) in Company
26Aug20 11:55 RNS-R IXICO Plc 8.16%
Investor presentation
24Aug20 07:00 RNS IXICO Plc 8.16%
Trading Update
13Aug20 07:00 RNS-R IXICO Plc 8.16%
Investor Presentation
08Jul20 07:00 RNS-R IXICO Plc 8.16%
Conference attendance - On Helix Digital
06Jul20 07:00 RNS IXICO Plc 8.16%
Grant of share options
24Jun20 07:00 RNS IXICO Plc 8.16%
Trading Update
20May20 07:00 RNS IXICO Plc 8.16%
Half yearly report to 31 March 2020
12May20 07:00 RNS IXICO Plc 8.16%
Notice of Results
20Apr20 07:00 RNS IXICO Plc 8.16%
Trading update for H1 2020
14Apr20 07:00 RNS IXICO Plc 8.16%
£10.5m contract win, update on trading & COVID-19
16Mar20 09:00 RNS-R IXICO Plc 8.16%
IXICO announces expanded contract with Vaccinex
19Feb20 09:00 RNS-R IXICO Plc 8.16%
IXICO to Present AI Segmentation Research
11Feb20 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
10Feb20 09:11 RNS-R IXICO Plc 8.16%
IXICO to Present at Innovation Forum
03Feb20 09:00 RNS-R IXICO Plc 8.16%
IXICO Supports the AD Neuroimaging Initiative
23Jan20 07:00 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
17Jan20 16:34 RNS IXICO Plc 8.16%
Result of AGM
15Jan20 10:32 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
13Jan20 13:29 RNS IXICO Plc 8.16%
Issue of Equity
23Dec19 07:00 RNS IXICO Plc 8.16%
IXICO announces updates to client contracts
20Dec19 07:00 RNS IXICO Plc 8.16%
Statement re Annual Report and Notice of AGM
09Dec19 09:26 RNS IXICO Plc 8.16%
PDMR share sale
09Dec19 07:02 RNS IXICO Plc 8.16%
Holding(s) in Company
09Dec19 07:00 RNS IXICO Plc 8.16%
PDMR share purchase
05Dec19 08:22 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
04Dec19 07:00 RNS IXICO Plc 8.16%
Financial Results for the year ended 30 Sept 2019
02Dec19 07:00 RNS-R IXICO Plc 8.16%
IXICO to Present at Alzheimer's Disease Congress
22Nov19 07:00 RNS IXICO Plc 8.16%
Notice of Results
05Nov19 09:00 RNS-R IXICO Plc 8.16%
IXICO to Present at HD and Ataxia Conferences
04Nov19 14:51 RNS IXICO Plc 8.16%
Holding(s) in Company
30Oct19 09:00 RNS-R IXICO Plc 8.16%
IXICO to Present at 10th Annual CNS Summit 2019
28Oct19 07:00 RNS IXICO Plc 8.16%
IXICO announces client contracts and appointed CBO
18Oct19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
15Oct19 07:00 RNS IXICO Plc 8.16%
Trading Update for year ended 30 September 2019
11Sep19 07:00 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
09Sep19 11:48 RNS IXICO Plc 8.16%
Holding(s) in Company
09Sep19 11:46 RNS IXICO Plc 8.16%
Holding(s) in Company
05Sep19 15:43 RNS IXICO Plc 8.16%
Holding(s) in Company
04Sep19 17:07 RNS IXICO Plc 8.16%
Holding(s) in Company
28Aug19 12:21 RNS IXICO Plc 8.16%
Issue of Equity
22Aug19 07:00 RNS IXICO Plc 8.16%
Directorate Change
20Aug19 17:38 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
19Aug19 07:00 RNS IXICO Plc 8.16%
Trading Update
09Aug19 07:00 RNS IXICO Plc 8.16%
IXICO provides update on new & current contracts
11Jul19 07:00 RNS IXICO Plc 8.16%
Director and PDMR share purchase
10Jun19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 RNS IP Group plc 0.74%
Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 RNS IXICO Plc 8.16%
Holding(s) in Company
22May19 07:00 RNS IXICO Plc 8.16%
Half Yearly Report to 31 March 2019
10May19 07:00 RNS IXICO Plc 8.16%
Notice of Results
25Apr19 07:00 RNS IXICO Plc 8.16%
Update for first half of year ending 31 March 2019
24Apr19 07:00 RNS IXICO Plc 8.16%
Announces two new biopharmaceutical contracts
12Apr19 07:00 RNS IXICO Plc 8.16%
Change of Adviser
19Mar19 16:20 RNS IXICO Plc 8.16%
Holding(s) in Company
18Mar19 12:24 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
13Mar19 07:00 RNS IXICO Plc 8.16%
Director/PDMR Shareholding
05Mar19 07:00 RNS-R IXICO Plc 8.16%
Late phase clinical study in Huntington's disease
01Mar19 07:00 RNS-R IXICO Plc 8.16%
IXICO chosen for new Medical Imaging & AI Centre
07Feb19 07:00 RNS IXICO Plc 8.16%
Appointment of Chief Financial Officer
11Dec18 07:00 RNS IXICO Plc 8.16%
Directorate Change
04Dec18 07:00 RNS IXICO Plc 8.16%
Final Results
04Dec18 07:00 RNS IXICO Plc 8.16%
Scope expanded with top 10 biopharma company
Date / Time Company % Chg
12Apr21 16:00 CIP LSE,IXI LSE 8.16%
Holding(s) in Company
12Apr21 07:00 CIP LSE,IXI LSE 8.16%
Investment in Ixico plc
01Apr21 07:00 IXICO Plc 8.16%
Holding(s) in Company
25Mar21 09:14 IXICO Plc 8.16%
PDMR Transaction
23Mar21 15:05 IXICO Plc 8.16%
Huntington’s disease Phase III contract updates
15Mar21 07:00 IXICO Plc 8.16%
Collaboration with Microsoft
10Mar21 07:00 IXICO Plc 8.16%
IXICO chosen for new Phase II AD study
02Mar21 07:00 IXICO Plc 8.16%
IXICO selected by Cyclerion for a new AD study
01Mar21 17:25 IXICO Plc 8.16%
Exercise of Options; PDMR Dealing
29Jan21 10:19 IXICO Plc 8.16%
PDMR Dealing
21Jan21 11:05 IXICO Plc 8.16%
Result of AGM
07Jan21 07:00 IXICO Plc 8.16%
Issue of Equity
24Dec20 07:00 IXICO Plc 8.16%
IXICO secures new contract for £3.4 million
14Dec20 11:54 IXICO Plc 8.16%
Holding(s) in Company
08Dec20 07:00 IXICO Plc 8.16%
IXICO contract with new large global pharma
02Dec20 07:00 IXICO Plc 8.16%
Financial Results for the year ended 30 Sept 2020
27Nov20 07:00 IXICO Plc 8.16%
IXICO announces £1.9 million new study award
09Nov20 07:00 IXICO Plc 8.16%
Notice of Results
03Nov20 07:00 IXICO Plc 8.16%
Additional Alzheimer’s disease contracts
22Oct20 07:00 IXICO Plc 8.16%
Further Huntington’s disease contracts
19Oct20 07:00 IXICO Plc 8.16%
IXICO to Present at SCA & ARCA Global Conference
19Oct20 07:00 IXICO Plc 8.16%
Trading Update for year ended 30 September 2020
16Oct20 07:00 IXICO Plc 8.16%
IXICO and NYU Langone Health sign agreement
29Sep20 07:00 IXICO Plc 8.16%
>£2m contract extension win - Huntington’s disease
24Sep20 07:00 IXICO Plc 8.16%
Collaboration with TRACK-FA NeuroimagingConsortium
21Sep20 07:00 IXICO Plc 8.16%
IXICO selected to support Alzheimer’s trial
11Sep20 10:36 IXICO Plc 8.16%
Holding(s) in Company
26Aug20 11:55 IXICO Plc 8.16%
Investor presentation
24Aug20 07:00 IXICO Plc 8.16%
Trading Update
13Aug20 07:00 IXICO Plc 8.16%
Investor Presentation
08Jul20 07:00 IXICO Plc 8.16%
Conference attendance - On Helix Digital
06Jul20 07:00 IXICO Plc 8.16%
Grant of share options
24Jun20 07:00 IXICO Plc 8.16%
Trading Update
20May20 07:00 IXICO Plc 8.16%
Half yearly report to 31 March 2020
12May20 07:00 IXICO Plc 8.16%
Notice of Results
20Apr20 07:00 IXICO Plc 8.16%
Trading update for H1 2020
14Apr20 07:00 IXICO Plc 8.16%
£10.5m contract win, update on trading & COVID-19
16Mar20 09:00 IXICO Plc 8.16%
IXICO announces expanded contract with Vaccinex
19Feb20 09:00 IXICO Plc 8.16%
IXICO to Present AI Segmentation Research
11Feb20 07:00 IXICO Plc 8.16%
Holding(s) in Company
10Feb20 09:11 IXICO Plc 8.16%
IXICO to Present at Innovation Forum
03Feb20 09:00 IXICO Plc 8.16%
IXICO Supports the AD Neuroimaging Initiative
23Jan20 07:00 IXICO Plc 8.16%
Director/PDMR Shareholding
17Jan20 16:34 IXICO Plc 8.16%
Result of AGM
15Jan20 10:32 IXICO Plc 8.16%
Director/PDMR Shareholding
13Jan20 13:29 IXICO Plc 8.16%
Issue of Equity
23Dec19 07:00 IXICO Plc 8.16%
IXICO announces updates to client contracts
20Dec19 07:00 IXICO Plc 8.16%
Statement re Annual Report and Notice of AGM
09Dec19 09:26 IXICO Plc 8.16%
PDMR share sale
09Dec19 07:02 IXICO Plc 8.16%
Holding(s) in Company
09Dec19 07:00 IXICO Plc 8.16%
PDMR share purchase
05Dec19 08:22 IXICO Plc 8.16%
Director/PDMR Shareholding
04Dec19 07:00 IXICO Plc 8.16%
Financial Results for the year ended 30 Sept 2019
02Dec19 07:00 IXICO Plc 8.16%
IXICO to Present at Alzheimer's Disease Congress
22Nov19 07:00 IXICO Plc 8.16%
Notice of Results
05Nov19 09:00 IXICO Plc 8.16%
IXICO to Present at HD and Ataxia Conferences
04Nov19 14:51 IXICO Plc 8.16%
Holding(s) in Company
30Oct19 09:00 IXICO Plc 8.16%
IXICO to Present at 10th Annual CNS Summit 2019
28Oct19 07:00 IXICO Plc 8.16%
IXICO announces client contracts and appointed CBO
18Oct19 07:00 IXICO Plc 8.16%
Holding(s) in Company
15Oct19 07:00 IXICO Plc 8.16%
Trading Update for year ended 30 September 2019
11Sep19 07:00 IXICO Plc 8.16%
Director/PDMR Shareholding
09Sep19 11:48 IXICO Plc 8.16%
Holding(s) in Company
09Sep19 11:46 IXICO Plc 8.16%
Holding(s) in Company
05Sep19 15:43 IXICO Plc 8.16%
Holding(s) in Company
04Sep19 17:07 IXICO Plc 8.16%
Holding(s) in Company
28Aug19 12:21 IXICO Plc 8.16%
Issue of Equity
22Aug19 07:00 IXICO Plc 8.16%
Directorate Change
20Aug19 17:38 IXICO Plc 8.16%
Director/PDMR Shareholding
19Aug19 07:00 IXICO Plc 8.16%
Trading Update
09Aug19 07:00 IXICO Plc 8.16%
IXICO provides update on new & current contracts
11Jul19 07:00 IXICO Plc 8.16%
Director and PDMR share purchase
10Jun19 07:00 IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 IPO LSE,IXI LSE 0.74%
Holding(s) in Company
31May19 07:00 IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 IXICO Plc 8.16%
Holding(s) in Company
31May19 07:00 IXICO Plc 8.16%
Holding(s) in Company
22May19 07:00 IXICO Plc 8.16%
Half Yearly Report to 31 March 2019
10May19 07:00 IXICO Plc 8.16%
Notice of Results
25Apr19 07:00 IXICO Plc 8.16%
Update for first half of year ending 31 March 2019
24Apr19 07:00 IXICO Plc 8.16%
Announces two new biopharmaceutical contracts
12Apr19 07:00 IXICO Plc 8.16%
Change of Adviser
19Mar19 16:20 IXICO Plc 8.16%
Holding(s) in Company
18Mar19 12:24 IXICO Plc 8.16%
Director/PDMR Shareholding
13Mar19 07:00 IXICO Plc 8.16%
Director/PDMR Shareholding
05Mar19 07:00 IXICO Plc 8.16%
Late phase clinical study in Huntington's disease
01Mar19 07:00 IXICO Plc 8.16%
IXICO chosen for new Medical Imaging & AI Centre
07Feb19 07:00 IXICO Plc 8.16%
Appointment of Chief Financial Officer
11Dec18 07:00 IXICO Plc 8.16%
Directorate Change
04Dec18 07:00 IXICO Plc 8.16%
Final Results
04Dec18 07:00 IXICO Plc 8.16%
Scope expanded with top 10 biopharma company